BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
100 hedge funds and large institutions have $714M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2018 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 18 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+10
Holders Change %
+11.11%
% of All Funds
2.3%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
24
Increased
51
Reduced
18
Closed
14
Calls
$72.7M
Puts
$9.85M
Net Calls
+$62.8M
Net Calls Change
+$59.5M
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$64.9M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$62.2M |
| 3 |
BlackRock
New York
|
+$18.9M |
| 4 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
+$16.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$14.5M |
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$42.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.6M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$13.5M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$10.1M |
| 5 |
VMI
VHCP Management II
New York
|
-$8.45M |
